So who do you believe? The Cleveland Clinic and Science, or the fauch and a part time secretary?


1 min read

Article can be found here.

So who do you believe? The Cleveland Clinic and Science, or the fauch and a part time secretary? As you know, the fauch has been spreading junk science about who should get the vaccine. And in the past I'VE told you about a part time secretary masquerading as a medical expert telling folks that the vaccine is the medical cure all when it comes to the virus. Real Scientists did this study.


Scientists from the Cleveland Clinic, USA, have recently evaluated the effectiveness of coronavirus disease 2019 COVID-19) vaccination among individuals with or without a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. 

The study findings reveal that individuals with previous SARS-CoV-2 infection do not get additional benefits from vaccination, indicating that COVID-19 vaccines should be prioritized to individuals without prior infection. The study is currently available on the medRxiv* preprint server.


The study was conducted on 52,238 employees in the Cleveland Clinic. A positive RT-PCR test was considered to define SARS-CoV-2 infection. The participants received two doses of the Pfizer/BioNTech or Moderna COVID-19 vaccine at an interval of 28 days. A participant was considered vaccinated after 14 days of receiving the 2nd vaccine dose. Similarly, a participant who tested positive for SARS-CoV-2 at least 42 days before the vaccination initiation was considered previously infected. 


Importantly, not a single incidence of SARS-CoV-2 infection was observed in previously infected participants with or without vaccination.

With further statistical analysis, it was observed that the COVID-19 vaccination significantly reduced the risk of SARS-CoV-2 infection in previously uninfected participants but not in previously infected participants. 

Although the study did not directly estimate the duration of protection from natural infection, it was observed that previously infected participants remained protected against COVID-19 for at least 10 months after the symptom onset or a positive test result.